中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
14期
229-231
,共3页
产科%弥漫性血管内凝血%预后
產科%瀰漫性血管內凝血%預後
산과%미만성혈관내응혈%예후
Obstetric%Disseminated intravascular coagulation%Prognosis
目的:探讨产科弥漫性血管内凝血的发生原因、治疗方案及其预后的影响因素。方法选择2006年1月~2014年1月在我院妇产科收治的28例发生弥漫性血管内凝血的孕妇作为本次临床观察的研究对象,回顾性分析孕妇发生弥漫性血管内凝血的原因及其临床表现,探讨弥漫性血管内凝血的临床治疗效果。结果28例孕妇均抢救成功,无产妇死亡病例;子宫全切除的患者有3例,次全子宫切除患者1例,子宫动脉灌注栓塞术患者6例。胎儿情况,新生儿存活27例,宫内死亡1例,死胎4例,新生儿死亡率为15.62%。患者在弥漫性血管内凝血治疗前后,凝血功能有明显区别。在治疗后,患者的凝血功能有着明显改善。结论弥漫性血管内凝血的治疗主要是及时并且有效地将引起弥漫性血管内凝血的病因去除,同时进行有效的止血、补充血容量等相关的对症治疗。子宫动脉灌注栓塞术及再次开腹探查时加行B-Lynch子宫缝扎术,对保留子宫起了非常重要的作用。
目的:探討產科瀰漫性血管內凝血的髮生原因、治療方案及其預後的影響因素。方法選擇2006年1月~2014年1月在我院婦產科收治的28例髮生瀰漫性血管內凝血的孕婦作為本次臨床觀察的研究對象,迴顧性分析孕婦髮生瀰漫性血管內凝血的原因及其臨床錶現,探討瀰漫性血管內凝血的臨床治療效果。結果28例孕婦均搶救成功,無產婦死亡病例;子宮全切除的患者有3例,次全子宮切除患者1例,子宮動脈灌註栓塞術患者6例。胎兒情況,新生兒存活27例,宮內死亡1例,死胎4例,新生兒死亡率為15.62%。患者在瀰漫性血管內凝血治療前後,凝血功能有明顯區彆。在治療後,患者的凝血功能有著明顯改善。結論瀰漫性血管內凝血的治療主要是及時併且有效地將引起瀰漫性血管內凝血的病因去除,同時進行有效的止血、補充血容量等相關的對癥治療。子宮動脈灌註栓塞術及再次開腹探查時加行B-Lynch子宮縫扎術,對保留子宮起瞭非常重要的作用。
목적:탐토산과미만성혈관내응혈적발생원인、치료방안급기예후적영향인소。방법선택2006년1월~2014년1월재아원부산과수치적28례발생미만성혈관내응혈적잉부작위본차림상관찰적연구대상,회고성분석잉부발생미만성혈관내응혈적원인급기림상표현,탐토미만성혈관내응혈적림상치료효과。결과28례잉부균창구성공,무산부사망병례;자궁전절제적환자유3례,차전자궁절제환자1례,자궁동맥관주전새술환자6례。태인정황,신생인존활27례,궁내사망1례,사태4례,신생인사망솔위15.62%。환자재미만성혈관내응혈치료전후,응혈공능유명현구별。재치료후,환자적응혈공능유착명현개선。결론미만성혈관내응혈적치료주요시급시병차유효지장인기미만성혈관내응혈적병인거제,동시진행유효적지혈、보충혈용량등상관적대증치료。자궁동맥관주전새술급재차개복탐사시가행B-Lynch자궁봉찰술,대보류자궁기료비상중요적작용。
Objective To explore the cause, treatment programs and prognostic factors of obstetric disseminated intravascular coagulation. Methods 28 pregnant women with disseminated intravascular coagulation in our hospital from January 2006 to January 2014 were selected, the cause and clinical manifestations of the pregnant women with disseminated intravascular coagulation were retrospectively analyzed. Results 28 pregnant women were all rescued successfully, no maternal deaths;3 cases had total hysterectomy, 1 case had subtotal hysterectomy, 6 cases had uterine arterial embolization. Fetal condition, 27 neonatal survived, 1 case was intrauterine death, 4 cases were stillbirth, neonatal mortality rate was 15.62%. Patients' coagulation function had significant differences before and after the treatment of disseminated intravascular coagulation. After the treatment, patients' coagulation function had been significantly improved. Conclusion In the treatment of disseminated intravascular coagulation, it is main to remove the cause of disseminated intravascular coagulation, while to give effective hemostasis, add volume and other related symptomatic treatment. It plays a very important role for reservations uterus of uterine arterial embolization and plus line B-Lynch suture uterus when Laparotomy again.